{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T18:56:06Z","timestamp":1781636166397,"version":"3.54.5"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:00:00Z","timestamp":1771459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:00:00Z","timestamp":1771459200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Imaging"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>To investigate the radiomics features of the hippocampus and the amygdala subregions in FDG-PET images that can best differentiate Mild Cognitive Impairment (MCI), Alzheimer\u2019s Disease (AD), and healthy patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Baseline FDG-PET data from 555 participants in the ADNI dataset were analyzed, comprising 189 cognitively normal (CN) individuals, 201 with MCI, and 165 with AD. We extracted 120 quantitative features from finely and automatically parcellated subregions (hippocampal\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200938, amygdala\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200918) using a probabilistic atlas. To identify the most effective classification model, we applied four feature selection techniques, ANOVA, PCA, LASSO, and Chi-square, combined with nine different classifiers, resulting in 36 unique model combinations. This comprehensive evaluation enabled the selection of a high-performing machine learning pipeline.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The Multi-Layer Perceptron (MLP) model combined with LASSO demonstrated excellent classification performance: ROC AUC of 0.957 for CN vs. AD, ROC AUC of 0.867 for MCI vs. AD, and ROC AUC of 0.782 for CN vs. MCI. Key regions, including the accessory basal nucleus, presubiculum head, and CA4 head, were identified as critical biomarkers. Features including GLRLM (Long Run Emphasis) and Small Dependence Emphasis (GLDM) showed strong diagnostic potential, reflecting subtle metabolic and microstructural changes often preceding anatomical alterations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Specific hippocampal and amygdala subregions and their four radiomic features were found to have a significant role in the early diagnosis of AD, its staging, and its severity assessment by capturing subtle shifts in metabolic patterns. Furthermore, these features offer potential insights into the disease\u2019s underlying mechanisms and model interpretability.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12880-026-02168-8","type":"journal-article","created":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T13:15:57Z","timestamp":1771506957000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Subregional limbic radiomics on FDG-PET provides accurate early detection of Alzheimer\u2019s disease"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-6657-2355","authenticated-orcid":false,"given":"Ramin","family":"Rasi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0490-5184","authenticated-orcid":false,"given":"Albert","family":"Guvenis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the Alzheimer\u2019s Disease Neuroimaging Initiative","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,19]]},"reference":[{"key":"2168_CR1","doi-asserted-by":"publisher","unstructured":"Zhang J, Zhang Y, Wang J, Xia Y, Zhang J, Chen L. Recent advances in alzheimer\u2019s disease: mechanisms, clinical trials and new drug development strategies. Signal Transduct Target Ther. Aug. 2024;9(1):211. https:\/\/doi.org\/10.1038\/s41392-024-01911-3.","DOI":"10.1038\/s41392-024-01911-3"},{"key":"2168_CR2","doi-asserted-by":"publisher","unstructured":"Counts SE, Ikonomovic MD, Mercado N, Vega IE, Mufson EJ. Biomarkers for the early detection and progression of alzheimer\u2019s disease. Neurotherapeutics. Jan. 2017;14(1):35\u201353. https:\/\/doi.org\/10.1007\/s13311-016-0481-z.","DOI":"10.1007\/s13311-016-0481-z"},{"key":"2168_CR3","doi-asserted-by":"publisher","unstructured":"van Dyck C. The development of neuroimaging methodologies to assist in the diagnosis and treatment of alzheimer\u2019s disease. Biol Psychiatry. May 2024;95(10). https:\/\/doi.org\/10.1016\/j.biopsych.2024.02.065.","DOI":"10.1016\/j.biopsych.2024.02.065"},{"key":"2168_CR4","doi-asserted-by":"publisher","unstructured":"Lista S, et al. A critical appraisal of blood-based biomarkers for alzheimer\u2019s disease. Ageing Res Rev. Apr. 2024;96:102290. https:\/\/doi.org\/10.1016\/j.arr.2024.102290.","DOI":"10.1016\/j.arr.2024.102290"},{"key":"2168_CR5","doi-asserted-by":"publisher","unstructured":"Hnilicova P, et al. Imaging methods applicable in the diagnostics of alzheimer\u2019s Disease, considering the involvement of insulin resistance. Int J Mol Sci. Feb. 2023;24(4):3325. https:\/\/doi.org\/10.3390\/ijms24043325.","DOI":"10.3390\/ijms24043325"},{"key":"2168_CR6","doi-asserted-by":"publisher","unstructured":"Dang C, Wang Y, Li Q, Lu Y. Neuroimaging modalities in the detection of alzheimer\u2019s disease-associated biomarkers. Psychoradiology. Mar. 2023;3. https:\/\/doi.org\/10.1093\/psyrad\/kkad009.","DOI":"10.1093\/psyrad\/kkad009"},{"key":"2168_CR7","doi-asserted-by":"publisher","unstructured":"Chaudhary S, Zhornitsky S, Chao HH, van Dyck CH, Li C-SR. emotion processing dysfunction in alzheimer\u2019s disease: an overview of behavioral findings, systems neural correlates, and underlying neural biology. Am J Alzheimers Dis Other Demen. 2022;37. https:\/\/doi.org\/10.1177\/15333175221082834","DOI":"10.1177\/15333175221082834"},{"key":"2168_CR8","doi-asserted-by":"publisher","unstructured":"C\u00e1rdenas J, Blanca MJ, Carvajal F, Rubio S, Pedraza C. Emotional processing in healthy Ageing, mild cognitive Impairment, and alzheimer\u2019s disease. Int J Environ Res Public Health. Mar. 2021;18(5):2770. https:\/\/doi.org\/10.3390\/ijerph18052770.","DOI":"10.3390\/ijerph18052770"},{"key":"2168_CR9","doi-asserted-by":"publisher","unstructured":"Xu J, Tan S, Wen J, Zhang M, Xu X. Progression of hippocampal subfield atrophy and asymmetry in Alzheimer\u2019s disease. Eur J Neurosci. Oct 2024;60(8):6091\u20136106. https:\/\/doi.org\/10.1111\/ejn.16543","DOI":"10.1111\/ejn.16543"},{"key":"2168_CR10","doi-asserted-by":"publisher","unstructured":"Wu X, et al. Amygdala neuronal dyshomeostasis via <\u2009scp\u2009>\u20095-HT\u2009receptors mediates mood and cognitive defects in alzheimer\u2019s disease. Aging Cell. Aug. 2024;23(8). https:\/\/doi.org\/10.1111\/acel.14187.","DOI":"10.1111\/acel.14187"},{"key":"2168_CR11","doi-asserted-by":"publisher","unstructured":"Izzo J, Andreassen OA, Westlye LT, van der Meer D. The association between hippocampal subfield volumes in mild cognitive impairment and conversion to alzheimer\u2019s disease. Brain Res. Feb. 2020;1728:146591. https:\/\/doi.org\/10.1016\/j.brainres.2019.146591.","DOI":"10.1016\/j.brainres.2019.146591"},{"key":"2168_CR12","doi-asserted-by":"publisher","unstructured":"Punzi M, et al. Atrophy of hippocampal subfields and amygdala nuclei in subjects with mild cognitive impairment progressing to Alzheimer\u2019s disease. Heliyon. 2024;10(6):e27429. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e27429","DOI":"10.1016\/j.heliyon.2024.e27429"},{"key":"2168_CR13","doi-asserted-by":"publisher","unstructured":"Katabathula S, Wang Q, Xu R. Predict alzheimer\u2019s disease using hippocampus MRI data: a lightweight 3D deep convolutional network model with visual and global shape representations. Alzheimers Res Ther. Dec. 2021;13(1):104. https:\/\/doi.org\/10.1186\/s13195-021-00837-0.","DOI":"10.1186\/s13195-021-00837-0"},{"key":"2168_CR14","doi-asserted-by":"publisher","unstructured":"Balasundaram A, Srinivasan S, Prasad A, Malik J, Kumar A. Hippocampus segmentation-based alzheimer\u2019s disease diagnosis and classification of MRI images. Arab J Sci Eng. Aug. 2023;48(8):10249\u201310265. https:\/\/doi.org\/10.1007\/s13369-022-07538-2","DOI":"10.1007\/s13369-022-07538-2"},{"key":"2168_CR15","doi-asserted-by":"publisher","unstructured":"Zhu Q, et al. Classification of alzheimer\u2019s disease based on abnormal hippocampal functional connectivity and machine learning. Front Aging Neurosci. Feb. 2022;14. https:\/\/doi.org\/10.3389\/fnagi.2022.754334.","DOI":"10.3389\/fnagi.2022.754334"},{"key":"2168_CR16","doi-asserted-by":"publisher","unstructured":"Qu H, Ge H, Wang L, Wang W, Hu C. Volume changes of hippocampal and amygdala subfields in patients with mild cognitive impairment and Alzheimer\u2019s disease. Acta Neurol Belg. Aug. 2023;123(4):1381\u20131393. https:\/\/doi.org\/10.1007\/s13760-023-02235-9","DOI":"10.1007\/s13760-023-02235-9"},{"key":"2168_CR17","doi-asserted-by":"publisher","unstructured":"Chen F. PET radiomics of white matter, can be employed as a biomarker to identify the progression of mild cognitive impairment to alzheimer\u2019s disease. Acad Radiol. Sep. 2023;30(9):1885\u20131886. https:\/\/doi.org\/10.1016\/j.acra.2023.06.020","DOI":"10.1016\/j.acra.2023.06.020"},{"issue":"1","key":"2168_CR18","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3348\/kjr.2021.0323","volume":"23","author":"R Song","year":"2022","unstructured":"Song R, et al. Prediction of cognitive progression in individuals with mild cognitive impairment using radiomics as an improvement of the ATN system: A Five-Year Follow-Up study. Korean J Radiol. 2022;23(1):89. https:\/\/doi.org\/10.3348\/kjr.2021.0323.","journal-title":"Korean J Radiol"},{"key":"2168_CR19","doi-asserted-by":"publisher","unstructured":"Fusco R, et al. Radiomics in medical imaging: pitfalls and challenges in clinical management. Jpn J Radiol. Sep. 2022;40(9):919\u201329. https:\/\/doi.org\/10.1007\/s11604-022-01271-4.","DOI":"10.1007\/s11604-022-01271-4"},{"key":"2168_CR20","doi-asserted-by":"publisher","unstructured":"Guiot J, et al. A review in radiomics: making personalized medicine a reality via routine imaging. Med Res Rev. 2022;42(1):426\u2013440. https:\/\/doi.org\/10.1002\/med.21846","DOI":"10.1002\/med.21846"},{"key":"2168_CR21","doi-asserted-by":"publisher","unstructured":"Salvatore C, Castiglioni I, Cerasa A. Radiomics approach in the neurodegenerative brain. Aging Clin Exp Res. Jun. 2021;33(6):1709\u201311. https:\/\/doi.org\/10.1007\/s40520-019-01299-z.","DOI":"10.1007\/s40520-019-01299-z"},{"key":"2168_CR22","doi-asserted-by":"publisher","unstructured":"Du Y, et al. The effect of hippocampal radiomic features and functional connectivity on the relationship between hippocampal volume and cognitive function in alzheimer\u2019s disease. J Psychiatr Res. Feb. 2023;158:382\u201391. https:\/\/doi.org\/10.1016\/j.jpsychires.2023.01.024.","DOI":"10.1016\/j.jpsychires.2023.01.024"},{"key":"2168_CR23","doi-asserted-by":"publisher","unstructured":"Magistretti PJ, Allaman I. A cellular perspective on brain energy metabolism and functional imaging. Neuron. May 2015;86(4):883\u2013901. https:\/\/doi.org\/10.1016\/j.neuron.2015.03.035.","DOI":"10.1016\/j.neuron.2015.03.035"},{"key":"2168_CR24","doi-asserted-by":"publisher","unstructured":"Vercruysse P, Vieau D, Blum D, Peters\u00e9n \u00c5, Dupuis L. Hypothalamic alterations in neurodegenerative diseases and their relation to abnormal energy metabolism. Front Mol Neurosci. Jan. 2018;11. https:\/\/doi.org\/10.3389\/fnmol.2018.00002.","DOI":"10.3389\/fnmol.2018.00002"},{"key":"2168_CR25","doi-asserted-by":"publisher","unstructured":"Zaletel I, Milutinovi\u0107 K, Baj\u010deti\u0107 M, Nowakowski RS. Differentiation of amyloid plaques between alzheimer\u2019s disease and non-alzheimer\u2019s disease individuals based on gray-level co-occurrence matrix texture analysis. Microsc Microanal. Oct. 2021;27(5):1146\u20131153. https:\/\/doi.org\/10.1017\/S1431927621012095","DOI":"10.1017\/S1431927621012095"},{"key":"2168_CR26","doi-asserted-by":"publisher","unstructured":"Rasi R, Guvenis A. Platform for the radiomics analysis of brain regions: the case of alzheimer\u2019s disease and metabolic imaging. Brain Disord. Dec. 2024;16:100168. https:\/\/doi.org\/10.1016\/j.dscb.2024.100168.","DOI":"10.1016\/j.dscb.2024.100168"},{"key":"2168_CR27","doi-asserted-by":"publisher","unstructured":"Hansson O. Biomarkers for neurodegenerative diseases. Nat Med. Jun. 2021;27(6):954\u201363. https:\/\/doi.org\/10.1038\/s41591-021-01382-x.","DOI":"10.1038\/s41591-021-01382-x"},{"key":"2168_CR28","doi-asserted-by":"publisher","unstructured":"Dewanjee S, et al. Altered glucose metabolism in alzheimer\u2019s disease: role of mitochondrial dysfunction and oxidative stress. Free Radic Biol Med. Nov. 2022;193:134\u201357. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2022.09.032.","DOI":"10.1016\/j.freeradbiomed.2022.09.032"},{"key":"2168_CR29","doi-asserted-by":"publisher","unstructured":"Gao Y, et al. Proteomic analysis of human hippocampal subfields provides new insights into the pathogenesis of Alzheimer\u2019s disease and the role of glial cells. Brain Pathology. Jul. 2022;32(4). https:\/\/doi.org\/10.1111\/bpa.13047","DOI":"10.1111\/bpa.13047"},{"key":"2168_CR30","doi-asserted-by":"publisher","unstructured":"Al-Ani L, Tao A, Dyke J, Chiang G, Ishii M. Amygdala atrophy as an early manifestation of alzheimer\u2019s disease (S39.005). Neurology. Apr. 2023;100(17_supplement_2). https:\/\/doi.org\/10.1212\/WNL.0000000000202128","DOI":"10.1212\/WNL.0000000000202128"},{"key":"2168_CR31","doi-asserted-by":"publisher","unstructured":"Tustison NJ, et al. The ANTsX ecosystem for quantitative biological and medical imaging. Sci Rep. Apr. 2021;11(1):9068. https:\/\/doi.org\/10.1038\/s41598-021-87564-6.","DOI":"10.1038\/s41598-021-87564-6"},{"key":"2168_CR32","doi-asserted-by":"publisher","unstructured":"Jagust WJ, Koeppe RA, Rabinovici GD, Villemagne VL, Harrison TM, Landau SM. The ADNI PET Core at 20. Alzheimer\u2019s & Dementia. Aug. 2024. https:\/\/doi.org\/10.1002\/alz.14165","DOI":"10.1002\/alz.14165"},{"key":"2168_CR33","doi-asserted-by":"publisher","unstructured":"Jack CR, et al. Overview of ADNI MRI. Alzheimer\u2019s Dement. Sep. 2024. https:\/\/doi.org\/10.1002\/alz.14166.","DOI":"10.1002\/alz.14166"},{"key":"2168_CR34","doi-asserted-by":"publisher","unstructured":"Henschel L, Conjeti S, Estrada S, Diers K, Fischl B, Reuter M. FastSurfer - a fast and accurate deep learning based neuroimaging pipeline. NeuroImage. Oct. 2020;219:117012. https:\/\/doi.org\/10.1016\/j.neuroimage.2020.117012.","DOI":"10.1016\/j.neuroimage.2020.117012"},{"key":"2168_CR35","doi-asserted-by":"publisher","unstructured":"Iglesias JE, et al. A computational atlas of the hippocampal formation using ex vivo, ultra-high resolution MRI: application to adaptive segmentation of in vivo MRI. NeuroImage. Jul. 2015;115:117\u201337. https:\/\/doi.org\/10.1016\/j.neuroimage.2015.04.042.","DOI":"10.1016\/j.neuroimage.2015.04.042"},{"key":"2168_CR36","doi-asserted-by":"publisher","unstructured":"Saygin ZM, et al. High-resolution magnetic resonance imaging reveals nuclei of the human amygdala: manual segmentation to automatic atlas. NeuroImage. Jul. 2017;155:370\u201382. https:\/\/doi.org\/10.1016\/j.neuroimage.2017.04.046.","DOI":"10.1016\/j.neuroimage.2017.04.046"},{"key":"2168_CR37","doi-asserted-by":"publisher","unstructured":"Iglesias JE, Van Leemput K, Augustinack J, Insausti R, Fischl B, Reuter M. Bayesian longitudinal segmentation of hippocampal substructures in brain MRI using subject-specific atlases. NeuroImage. Nov. 2016;141:542\u201355. https:\/\/doi.org\/10.1016\/j.neuroimage.2016.07.020.","DOI":"10.1016\/j.neuroimage.2016.07.020"},{"key":"2168_CR38","doi-asserted-by":"publisher","unstructured":"van Griethuysen JJM, et al. Computational radiomics system to Decode the radiographic phenotype. Cancer Res. Nov. 2017;77(21):e104\u20137. https:\/\/doi.org\/10.1158\/0008-5472.CAN-17-0339.","DOI":"10.1158\/0008-5472.CAN-17-0339"},{"key":"2168_CR39","doi-asserted-by":"publisher","unstructured":"Mirzaei G, Adeli H. Machine learning techniques for diagnosis of alzheimer disease, mild cognitive disorder, and other types of dementia. Biomed Signal Process Control. Feb. 2022;72:103293. https:\/\/doi.org\/10.1016\/j.bspc.2021.103293.","DOI":"10.1016\/j.bspc.2021.103293"},{"key":"2168_CR40","doi-asserted-by":"publisher","unstructured":"Carlson ML, et al. Simultaneous FDG-PET\/MRI detects hippocampal subfield metabolic differences in AD\/MCI. Sci Rep. Jul. 2020;10(1):12064. https:\/\/doi.org\/10.1038\/s41598-020-69065-0.","DOI":"10.1038\/s41598-020-69065-0"},{"key":"2168_CR41","doi-asserted-by":"publisher","unstructured":"Huang B, et al. Memories and mimics: unveiling the potential of FDG-PET in guiding therapeutic approaches for neurodegenerative cognitive disorders. Front Neurol. Nov. 2024;15. https:\/\/doi.org\/10.3389\/fneur.2024.1428036.","DOI":"10.3389\/fneur.2024.1428036"},{"key":"2168_CR42","doi-asserted-by":"publisher","unstructured":"Singh K, Barsoum S, Schilling KG, An Y, Ferrucci L, Benjamini D. Neuronal microstructural changes in the human brain are associated with neurocognitive aging. Aging Cell. Jul. 2024;23(7). https:\/\/doi.org\/10.1111\/acel.14166","DOI":"10.1111\/acel.14166"},{"key":"2168_CR43","doi-asserted-by":"publisher","unstructured":"Rao YL, Ganaraja B, Murlimanju BV, Joy T, Krishnamurthy A, Agrawal A. Hippocampus and its involvement in Alzheimer\u2019s disease: a review. 3 Biotech. Feb. 2022;12(2):55. https:\/\/doi.org\/10.1007\/s13205-022-03123-4","DOI":"10.1007\/s13205-022-03123-4"},{"key":"2168_CR44","doi-asserted-by":"publisher","unstructured":"Padulo C, et al. Atrophy of specific amygdala subfields in subjects converting to mild cognitive impairment. Alzheimer\u2019s Dementia: Translational Res Clin Interventions. Oct. 2023;9(4). https:\/\/doi.org\/10.1002\/trc2.12436.","DOI":"10.1002\/trc2.12436"},{"key":"2168_CR45","doi-asserted-by":"publisher","unstructured":"Stouffer KM, et al. Amidst an amygdala renaissance in Alzheimer\u2019s disease. Brain. 2024;147(3):816\u2013829. https:\/\/doi.org\/10.1093\/brain\/awad411","DOI":"10.1093\/brain\/awad411"},{"key":"2168_CR46","doi-asserted-by":"publisher","unstructured":"Benarroch EE. The amygdala. Neurology. Jan. 2015;84(3):313\u201324. https:\/\/doi.org\/10.1212\/WNL.0000000000001171.","DOI":"10.1212\/WNL.0000000000001171"},{"key":"2168_CR47","doi-asserted-by":"publisher","unstructured":"F. Tamer and \u00dc. Yararba\u015f, alterations in 18F-FDG uptake patterns may limit cross-sectional evaluation of adrenal adenomas using single 18F-FDG PET\/CT imaging. Mol Imaging Radionucl Ther. Oct. 2023;32(3):247\u2013249. https:\/\/doi.org\/10.4274\/mirt.galenos.2023.98216.","DOI":"10.4274\/mirt.galenos.2023.98216"},{"key":"2168_CR48","doi-asserted-by":"publisher","unstructured":"Wagner MW, Namdar K, Biswas A, Monah S, Khalvati F, Ertl-Wagner BB. Radiomics, machine learning, and artificial intelligence\u2014what the neuroradiologist needs to know. Neuroradiology. Dec. 2021;63(12):1957\u20131967. https:\/\/doi.org\/10.1007\/s00234-021-02813-9","DOI":"10.1007\/s00234-021-02813-9"}],"container-title":["BMC Medical Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-026-02168-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12880-026-02168-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-026-02168-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T18:30:50Z","timestamp":1781634650000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12880-026-02168-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,19]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2168"],"URL":"https:\/\/doi.org\/10.1186\/s12880-026-02168-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7407302\/v1","asserted-by":"object"}]},"ISSN":["1471-2342"],"issn-type":[{"value":"1471-2342","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,19]]},"assertion":[{"value":"19 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was not required, as the study only used publicly available de-identified data from the ADNI.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"98"}}